If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
220.60    2.20 (1.01%)
Bid:
219.80
Ask:
220.00
Spread: 0.20 (0.091%)
Market Cap: £1.43b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Result of AGM

16 Oct 2020 16:14

RNS Number : 3828C
Ashmore Group PLC
16 October 2020
 

 

Ashmore Group plc

16 October 2020

Results of Annual General Meeting ("AGM")

 

 

Ashmore Group plc held its AGM earlier today and in view of the COVID-19 pandemic it was held as a 'closed meeting', attended by the minimum necessary quorum of two shareholders. All valid proxy votes were included in the poll taken at the meeting.

 

All resolutions were passed. Resolutions 5, 6, 7 and 8, relating to the re-election of Independent Non-Executive Directors, were carried by a majority of votes cast by both Independent Shareholders as well as by a majority of votes cast by all shareholders.

 

The Company welcomes the approval by shareholders of its Remuneration Policy and Remuneration Report, however it notes the 30.84% vote against the Remuneration Policy. The Company has an ongoing programme of engagement with its shareholders and proxy advisers and consequently it understands the views held by certain governance teams. This engagement will continue and the Company will provide an update within the next six months, as required by the UK Corporate Governance Code 2018.

 

The results of the poll on each resolution were as follows:

 

 

 

 

 

Resolution number:

FOR

AGAINST

ABSTAIN*

TOTAL VOTE

 

% age of total votes in favour

No. of Votes

 

No. of Votes

 

No. of Votes

 

1

 

To receive and adopt the Report and Accounts for the year ended 30 June 2020

595,353,065

776,200

1,565,996

596,129,265

99.87

2

 To declare a final dividend for the year ended 30 June 2020 of 12.1 pence per Ordinary Share

597,695,261

0

0

597,695,261

100.00

3

To re-elect Mark Coombs as a Director

595,016,718

2,678,113

430

597,694,831

99.55

4

To re-elect Tom Shippey as a Director

595,072,219

2,622,612

430

597,694,831

99.56

5

To re-elect Clive Adamson as a Director (all shareholders)

562,794,706

34,900,125

430

597,694,831

94.16

5

To re-elect Clive Adamson as a Director (independent shareholders)

319,347,233

34,900,125

430

 

354,247,358

90.15

 

6

 To re-elect David Bennett as a Director (all shareholders)

559,193,500

37,272,606

1,229,155

596,466,106

93.75

 

6

 To re-elect David Bennett as a Director (independent shareholders)

315,746,027

37,272,606

1,229,155

353,018,633

89.44

 

7

To elect Jennifer Bingham as a Director (all shareholders)

563,192,046

34,502,785

430

 

597,694,831

94.23

 

7

To elect Jennifer Bingham as a Director (independent shareholders)

319,744,573

34,502,785

430

 

354,247,358

90.26

 

8

To re-elect Dame Anne Pringle as a Director (all shareholders)

537,392,969

 

60,302,292

0

 

597,695,261

89.91

 

8

To re-elect Dame Anne Pringle as a Director (independent shareholders)

293,945,496

60,302,292

0

 

354,247,788

82.98

 

9

To approve the Directors' remuneration policy

386,652,049

172,385,927

38,657,285

559,037,976

69.16

10

To approve the Remuneration Report for the year ended 30 June 2020

538,465,590

59,225,066

4,605

597,690,656

90.09

11

To re-appoint KPMG LLP as auditors

511,426,634

83,671,233

2,597,394

595,097,867

85.94

12

To authorise the Audit and Risk Committee to agree the remuneration of the auditors

589,968,176

7,724,715

2,370

597,692,891

98.71

13

To authorise political donations and political expenditure

575,734,797

3,810,118

18,150,346

579,544,915

99.34

14

To authorise the Directors to allot shares

593,449,991

4,240,600

4,670

597,690,591

99.29

15

To authorise the dis-application of pre-emption rights up to 35,637,040 shares**

597,591,907

98,410

4,944

597,690,317

99.98

16

To authorise the dis-application of pre-emption rights up to a further 35,637,040 shares**

595,616,663

2,073,654

4,944

597,690,317

99.65

17

To authorise market purchases of shares**

594,859,010

2,768,176

68,075

597,627,186

99.54

18

To approve the renewal of the waiver of the obligation under Rule 9 of the Takeover Code ***

333,094,999

20,064,810

1,087,979

353,159,809

94.32

19

To reduce the notice period for general meetings other than an Annual General Meeting**

589,120,951

8,572,370

1,940

597,693,321

98.57

20

To adopt the New Articles**

597,684,220

5,171

5,870

597,689,391

100.00

 

 

* A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.

 

** Indicates Special Resolutions requiring a 75% majority

*** Mark Coombs has not voted on Resolution 18 as an interested party

 

Ashmore Group PLC's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12

 

In accordance with LR 9.6.2R, copies of resolutions concerning special business passed at the Annual General Meeting today, have been submitted to the Financial Conduct Authority's national storage mechanism. This document will shortly be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

 

For further details, please contact:

 

John Taylor

Group Company Secretary

Ashmore Group plc

61 Aldwych

London WC2B 4AE

 

+44 (0)20 3077 6000

 

 

FTI Consulting

 

Neil Doyle +44 (0)20 3727 1141

Laura Ewart +44 (0)20 3727 1160

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGMFBATMTBBBTM
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.